High-Flow Nasal Oxygen for Robotic Surgery

(Periop HFNO Trial)

This trial examines whether high-flow nasal oxygen (a special method of delivering oxygen) during robotic-assisted surgery can reduce breathing problems during and after the procedure. It aims to prevent low oxygen levels and lung issues in patients undergoing specific surgeries, such as those in the abdomen or chest, lasting at least two hours. Suitable candidates for this trial are adults undergoing these surgeries who will not require intensive care afterward. As an unphased trial, it provides patients the chance to contribute to significant research that could enhance surgical outcomes.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that high-flow nasal oxygen (HFNO) is generally safe during surgery. Studies have found that it can improve oxygen levels and ease breathing. For instance, one study discovered that HFNO allowed patients to maintain higher oxygen levels and experience fewer breathing problems during surgery compared to traditional methods.

Researchers are excited about high-flow nasal oxygen for robotic surgery because it offers a new way to maintain oxygen levels during anesthesia. Unlike the standard approach, which involves conventional preoxygenation and does not provide active oxygen during the apneic phase, high-flow nasal oxygen delivers a continuous stream of oxygen. This could lead to better oxygenation during critical periods, like induction and recovery, potentially improving patient outcomes and safety. Additionally, it may offer a more comfortable experience for patients compared to face masks or standard nasal cannulas.

This trial will compare high-flow nasal oxygen (HFNO) with standard care during robotic surgery. Studies have shown that HFNO can be very effective during surgery. Research indicates that HFNO improves oxygen levels in patients more effectively than traditional face masks. It significantly increases blood oxygen levels, easing patients' breathing. Evidence also suggests that HFNO reduces the risk of low oxygen levels after surgery, which is crucial for recovery. Additionally, it helps maintain stable oxygen levels even when breathing temporarily stops during surgery. This treatment offers a promising way to enhance patient safety during robotic surgeries.²⁴⁶⁷⁸